BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 1439110)

  • 1. False positivity of tumor markers in pleural fluid of traumatic hemothorax.
    Foresti V; Parisio E; De Filippi G
    Recenti Prog Med; 1992 May; 83(5):295-7. PubMed ID: 1439110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical evaluation of various tumor markers in pleural effusion and in the serum].
    Jibiki K; Abe Y; Takeda M; Iwachika C; Odagiri E; Demura R; Demura H
    Gan No Rinsho; 1989 Aug; 35(9):991-8. PubMed ID: 2769951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic value of three tumor markers determined in pleural effusions.
    Conejo JR; Benedito JE; Jimenez A; Menchen M; Cano J; Granizo V; Larrodera L
    Eur J Clin Chem Clin Biochem; 1996 Feb; 34(2):139-42. PubMed ID: 8833646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical evaluation of four tumor markers in malignant and benign pleural effusions.
    Toumbis M; Chondros K; Ferderigos AS; Daganou M; Dema A; Dalamaga A; Kakari S; Stringou E
    Anticancer Res; 1992; 12(4):1267-70. PubMed ID: 1503419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A clinical evaluation of CA 125 levels in serum, ascites and pleural effusion].
    Jibiki K; Demura R; Abe Y; Odagiri E; Demura H
    Gan No Rinsho; 1987 Nov; 33(14):1756-62. PubMed ID: 3480363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Diagnostic value of tissue polypeptide antigen in pleural effusions with malignant pleural mesothelioma].
    Tokuyama T; Yoneda T; Hamada K; Yoshikawa M; Fu A; Tomoda K; Nakaya M; Narita N; Tamura M; Kitamura K
    Nihon Kyobu Shikkan Gakkai Zasshi; 1995 Jan; 33(1):39-43. PubMed ID: 7699966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Tumor marker in lung cancer].
    Shijubo N; Abe S
    Kokyu To Junkan; 1993 Jun; 41(6):551-5. PubMed ID: 7687790
    [No Abstract]   [Full Text] [Related]  

  • 8. Tumor type M2-pyruvate-kinase levels in pleural fluid versus plasma in cancer patients: a further tool to define the need for invasive procedures.
    Elia S; Massoud R; Guggino G; Cristino B; Cortese C; De Massimi AR; Zenobi R
    Eur J Cardiothorac Surg; 2008 Apr; 33(4):723-7. PubMed ID: 18261916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic significance of cancer antigen 125, pancreatic oncofetal antigen, and carcinoembryonic antigen in malignant and tuberculous pleural effusions.
    Niwa Y; Shimokata K
    Jpn J Clin Oncol; 1986 Mar; 16(1):3-8. PubMed ID: 3009919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [CA 125 in the department of internal medicine--a marker of ovarian tumor, thoracic fluid or ascites?].
    Kasalický P; Kocián J
    Vnitr Lek; 1998 Aug; 44(8):478-80. PubMed ID: 10358454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical value of CYFRA21-1, NSE, CA15-3, CA19-9 and CA125 assay in the elderly patients with pleural effusions.
    Li CS; Cheng BC; Ge W; Gao JF
    Int J Clin Pract; 2007 Mar; 61(3):444-8. PubMed ID: 17313612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Carbohydrate antigens in pleural effusion from patients with lung cancer].
    Hiratani K; Sakito O; Mukae H; Morikawa N; Kadota J; Fukushima K; Komori K; Hirota M; Hara K
    Nihon Kyobu Shikkan Gakkai Zasshi; 1989 Jun; 27(6):673-8. PubMed ID: 2552211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A clinical study on CEA, TPA, ADA, ferritin, beta 2 microglobulin and sialic acid levels in pleural effusion].
    Reshad K; Suzuki K; Itoi K; Takahashi Y; Hirata T; Yagi T; Sato A; Nakano Y
    Nihon Kyobu Shikkan Gakkai Zasshi; 1987 Nov; 25(11):1174-80. PubMed ID: 3329690
    [No Abstract]   [Full Text] [Related]  

  • 14. [Tumor markers in ovarian cancer].
    Lahousen M
    Jugosl Ginekol Perinatol; 1987; 27(3-4):73-5. PubMed ID: 3481005
    [No Abstract]   [Full Text] [Related]  

  • 15. [Diagnostic value of the combined determination of carcinoembryonic antigen (CEA) in pleural effusion and serum with an enzyme immunoassay (EIA). Sensitivity, specificity and relation to tumor type].
    Klech H; Rona G; Hutter C; Bayer PM; Kummer F
    Wien Klin Wochenschr; 1986 Sep; 98(17):564-73. PubMed ID: 3020811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated pleural fluid RCAS1 is a diagnostic marker and outcome predictor in lung cancer patients.
    Aoe K; Hiraki A; Yamazaki K; Nakamura Y; Murakami T; Maeda T; Nishimura M; Sugi K; Ueoka H
    Int J Oncol; 2006 Jul; 29(1):65-72. PubMed ID: 16773186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of carcinoma cells in ascitic and pleural fluid. Comparison of four panepithelial antigens with carcinoembryonic antigen.
    Mezger J; Stötzer O; Schilli G; Bauer S; Wilmanns W
    Acta Cytol; 1992; 36(1):75-81. PubMed ID: 1546516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of ferritin, interleukin-6, interleukin-8 and tumor necrosis factor alpha in the differentiation of exudates and transudates in pleural effusions.
    Alexandrakis MG; Coulocheri SA; Bouros D; Eliopoulos GD
    Anticancer Res; 1999; 19(4C):3607-12. PubMed ID: 10629659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Diagnostic utility of carcinoembryonic antigen, neuron-specific enolase and squamous cell carcinoma antigen in malignant pleural effusion].
    Sánchez de Cos Escuín J; López Parra S; Disdier Vicente C; Martín Vicente MJ; Masa Jiménez JF; Domínguez Retortillo C
    An Med Interna; 1996 Aug; 13(8):369-73. PubMed ID: 8983362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical evaluation of tumor markers in breast cancer patients].
    Ito T; Tanaka S; Ban K; Sakai N; Oshita H; Oiwa T; Kanno A; Kashizuka T
    Gan To Kagaku Ryoho; 1987 Oct; 14(10):2917-23. PubMed ID: 3310907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.